ArticleBMC infectious diseases2025
Creating a prediction model for invasive candidiasis in the intensive care unit using a case control design: a European multicentre approach.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeInvasive candidiasis (IC) has a high attributable morbidity and mortality in patients in the intensive care unit (ICU). Current diagnostic tools lack sensitivity, introduce delay or have not been validated for regular use. As early treatment has proven vital for survival, multiple prediction models have been proposed but have not been validated for multinational implementation. In this study we propose to find factors predisposing the ICU patient to develop IC. We hope to develop an alternative prediction model using a large international dataset.
methodsUsing ICU-acquired IC as primary endpoint we retrieved retrospective information about 285 cases and 285 matched controls from the EUCANDICU database. Data about comorbidities, severity of illness and known risk factors for IC were available. We identified 31 independent risk factors using univariate analysis. A random subset of 80% of the observations were used to find the optimal prediction model. The selection of predictors was done using the LASSO technique, using λ = 1SE as regularization parameter. This choice for λ implies that a small amount of precision of the prediction is sacrificed to improve the external validity. The remaining 20% of cases were used to assess the predictive performance of the model.
resultsAmong other factors SAPS II score, SOFA score, past infection, renal impairment and the presence of multiple Candida colonization sites were all independently associated with an increased risk of developing IC. We incorporated 22 of 31 variables in a LASSO regression analysis which showed an AUROC of 0.7433.
conclusionPredicting which ICU patient will develop invasive candidiasis remains challenging, despite using an alternative methodology in a large multinational database. The performance of this prediction model is not good enough to be used in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.